Summary by Futu AI
Jin Medical International Ltd. has announced an Extraordinary General Meeting (EGM) to be held on January 30, 2024, at 9.30 a.m. Beijing Time, with a record date of January 12, 2024. The primary agenda for the EGM is to seek shareholder approval for the subdivision of each issued and unissued ordinary share with a par value of US$0.001 into twenty ordinary shares with a par value of US$0.00005 each. This move, if approved, would increase the authorized share capital to US$50,000 divided into 1,000,000,000 shares. The Board unanimously recommends a vote in favor of the proposal. The subdivision is a strategic response to a letter from Nasdaq's Listing Qualifications Department, which indicated the company's non-compliance with the minimum public holder requirement. A...Show More